What is the recommended cephalexin dosing for wound infection in adults (including dose adjustments for mild versus severe infection and for impaired renal function) and in children (including weight‑based dosing)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Dosing for Wound Infections

For adults with wound infections, cephalexin 500 mg four times daily (QID) is the standard dose, while children should receive 25-50 mg/kg/day divided into four doses, with consideration for twice-daily dosing (BID) to improve adherence. 1

Adult Dosing

Standard Dosing

  • Mild to moderate skin and soft tissue infections: 500 mg QID (every 6 hours) orally 2, 1
  • Alternative regimen: 500 mg every 12 hours (BID) for uncomplicated skin infections 1
  • Severe infections: Doses may be doubled, though if >4 g/day is required, parenteral cephalosporins should be considered 1

The FDA label explicitly states that 500 mg every 12 hours is acceptable for skin and skin structure infections 1, and emerging evidence supports BID dosing for improved adherence without compromising efficacy 3, 4.

Renal Dose Adjustments

Patients with creatinine clearance <30 mL/min require dose reduction proportional to their reduced renal function 5, 6. While the FDA label doesn't provide specific adjustment tables, cephalexin is 70-100% renally excreted within 6-8 hours 5. In anephric patients, single doses produce high, prolonged serum concentrations, necessitating significant dose reduction 6.

Pediatric Dosing

Standard Weight-Based Dosing

  • Usual dose: 25-50 mg/kg/day divided into 4 doses (QID) 1
  • For skin infections: Total daily dose may be divided every 12 hours (BID) in children >1 year 1
  • Severe infections: Dosage may be doubled 1

Practical Dosing by Weight (QID regimen):

Using 250 mg/5 mL suspension 1:

  • 10 kg (22 lb): 1/2 to 1 tsp QID
  • 20 kg (44 lb): 1 to 2 tsp QID
  • 40 kg (88 lb): 2 to 4 tsp QID

Alternative BID Regimen (Improved Adherence):

Recent pharmacokinetic modeling supports less frequent dosing 3:

  • For MSSA with MIC 1-2 mg/L: 22-45 mg/kg/dose BID
  • For MSSA with MIC 4 mg/L: 80 mg/kg/dose BID

High-dose TID regimen (45 mg/kg/dose, maximum 1.5 g TID) has demonstrated 99% cure rates in bone and joint infections with good tolerability 7, though this is higher than standard wound infection dosing.

Clinical Context and Guideline Framework

The 2014 IDSA guidelines position cephalexin as appropriate for methicillin-susceptible Staphylococcus aureus (MSSA) skin and soft tissue infections 2. It's specifically recommended for penicillin-allergic patients except those with immediate hypersensitivity reactions 2.

Key Considerations:

  • Duration: Typically 7-10 days for skin infections 2
  • MRSA coverage: Cephalexin does NOT cover MRSA; if suspected, alternative agents (trimethoprim-sulfamethoxazole, doxycycline, clindamycin) are needed 2
  • Wound type matters: For animal bites, amoxicillin-clavulanate is preferred over cephalexin due to better anaerobic coverage 2, 8

Common Pitfalls:

  1. Don't use cephalexin for necrotizing infections - these require broader coverage with agents like piperacillin-tazobactam plus clindamycin 2
  2. Avoid in patients with immediate penicillin hypersensitivity - cross-reactivity risk exists 2
  3. Remember renal adjustment - failure to reduce dose in renal impairment can lead to accumulation 5, 6

Adherence Optimization:

BID dosing significantly improves adherence compared to QID without compromising efficacy 3, 4, 9. A pilot RCT showed high-dose cephalexin (1000 mg QID) had fewer treatment failures (3.2%) versus standard dose (12.9%), though with more minor adverse effects 4. For pediatric patients, BID or TID regimens reduce medication burden and improve compliance 3, 7.

The WHO Essential Medicines list includes cephalexin as a first-choice agent for mild skin infections alongside amoxicillin-clavulanate 8, reinforcing its role as a foundational antibiotic for wound management when MSSA is the likely pathogen.

Related Questions

What is the recommended dosage of Keflex (Cephalexin) for a 9-year-old female?
What is the recommended cephalexin dosing for adult cellulitis, including dosage for uncomplicated versus severe infection, duration of therapy, and adjustments for renal impairment or β‑lactam allergy?
What is the recommended cephalexin dosing for cellulitis in adults and children, and how should the dose be adjusted for renal impairment or MRSA risk?
What should I do for stomach pain and acid reflux while taking Keflex (cephalexin)?
Can a patient with an estimated glomerular filtration rate of 20–29 mL/min safely receive cefalexin (Keflex)?
What is the appropriate emergency department evaluation and management for a dialysis patient presenting with acute symptoms?
How should a transfusion‑dependent female with thalassemia and heavy menstrual bleeding be managed, including the hemoglobin transfusion trigger and recommended transfusion frequency?
How should direct oral anticoagulants be used in patients with acute kidney injury or chronic kidney disease?
For an elderly patient with a urinary culture indicating ceftriaxone (Rocephin) as the optimal antibiotic, what dose should be prescribed per administration and for how many days?
What additional tests are indicated for evaluating a transfusion‑dependent female with thalassemia who has heavy menstrual bleeding?
Why should a 75-year-old male be prescribed a reduced (half‑strength) Paxlovid regimen (150 mg nirmatrelvir plus 50 mg ritonavir twice daily)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.